Skip to main content
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries

Quest Diagnostics (NY:DGX)

173.76 -2.11 (-1.20%)
Official Closing Price Updated: 7:00 PM EDT, Apr 25, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Headline News about Quest Diagnostics

< Previous 1 2 3 4 5 6 7 8 9 10 Next >
The Daily Biotech Pulse: Novartis Prostate Cancer Drug Lands FDA Approval, Ligand Announces SPAC Deal To Spin Off Antibody Business, Lilly's Lung Cancer Therapy Hit With CRL
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
7 Healthcare Stocks to Buy for the Long Term
When the markets go through the massive transitions they're seeing right now, it's a great time to add quality healthcare stocks. 
Via InvestorPlace
This Foreboding Sign Looms Over Quest Diagnostics's Chart
If history is any guide, there may be trouble ahead for shares of Quest Diagnostics (NYSE:DGX). A so-called "death cross" has formed on its chart and, not surprisingly, this... 
Via Benzinga
A Look Into Healthcare Sector Value Stocks
What is a Value Stock? A value stock is traditionally defined in terms of how investors in the marketplace are valuing that company's future growth prospects. Low P/E multiples... 
Via Benzinga
Earnings Scheduled For February 3, 2022
Companies Reporting Before The Bell • Tuesday Morning (NASDAQ:TUEM) is likely to report earnings for its second quarter. 
Via Benzinga
What 8 Analyst Ratings Have To Say About Quest Diagnostics
Analysts have provided the following ratings for Quest Diagnostics (NYSE:DGX) within the last quarter: Bullish Somewhat Bullish Indifferent Somewhat Bearish Bearish Total... 
Via Benzinga
Quest Diagnostics Q4 Earnings, FY22 Reflects Lower Demand For COVID-19 Testing Services
Quest Diagnostics Incorporated (NYSE: DGX) posted a better-than-expected  
Via Benzinga
The Daily Biotech Pulse: Big Pharma Earnings Prove Lackluster, Mersana Inks $1B ADC R&D Deal, Syros Gets Orphan Drug Designation
Here's a roundup of top developments in the biotech space over the last 24 hours: 
Via Benzinga
Recap: Quest Diagnostics Q4 Earnings
  Quest Diagnostics (NYSE:DGX) reported its Q4 earnings results on Thursday, February 3, 2022 at 06:45 AM. Here's what investors need to know about the announcement. 
Via Benzinga
7 Undervalued Stocks That Won’t Stay That Way for Long
With growing concerns about stability inducing significant fear, contrarians may have an opportunity with undervalued stocks. 
Via InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For February 2, 2022
Upgrades Oppenheimer upgraded the previous rating for NovoCure Ltd (NASDAQ:NVCR) from Perform to Outperform. NovoCure earned $0.13 in the third quarter, compared to $0.09... 
Via Benzinga
FeganScott Announces Investigation into Prenatal Testing Options Revealing Flawed Genetic Results
--News Direct-- 
Via News Direct
26 Firms Going Ex-Dividend Next Week, Including CVS Health, APA Corp. And Procter & Gamble
There are several well known large cap stocks going ex-dividend next week including 4 of our Top 100 Dividend Stocks. 
Via Talk Markets
Monday Is Your Last Chance To Buy Quest Diagnostics Before The Dividend Payout
Monday marks the last chance for investors to receive the next dividend payout from Quest Diagnostics. What's Happening (NYSE: 
Via Benzinga
Quest Diagnostics Inc Slammed After Earnings, Here’s Where It's Going
The next major support level for Quest Diagnostics Inc stock will be around the $140.00 level. This support area is where the stock broke out to the upside in early November 2021. 
Via Talk Markets
Quest Diagnostics Stock Falls As FY22 EPS Outlook Lags Consensus
Quest Diagnostics Inc (NYSE: DGX) expects Q4 sales of $2.74 billion, a decrease of 9% Y/Y, beating the consensus of $2.54 billion. The company noted preliminary Q4... 
Via Benzinga
Free COVID Tests: What Stocks Will Benefit?
The government hasn’t announced yet what company or companies it will be buying from, but there are several businesses involved in producing these kits. 
Via Talk Markets
QDEL Stock Alert: What Is Going on With Quidel Today?
The nearing holidays mean an increasing demand for Covid-19 testing kits. Leading provider Quidel is seeing QDEL stock rise as a result. 
Via InvestorPlace
Price Over Earnings Overview: Quest Diagnostics
In the current session, Quest Diagnostics Inc. (NYSE:DGX) is trading at $163.60, after a 0.21% gain. Over the past month, the stock increased by 10.55%, and in the past... 
Via Benzinga
Overview Of Value Stocks In The Healthcare Sector
What are Value Stocks? A value stock traditionally has a lower price when compared to stock prices of companies in the same industry. This indicates that the company may be... 
Via Benzinga
7 Stocks to Buy as America Lifts Its Travel Ban
With the Biden administration making the move to open U.S. land borders with Canada and Mexico, these stocks to buy can get a boost. 
Via InvestorPlace
Exposures COVID-19
Why This Diagnostics Stock Is a Buy
Quest Diagnostics beat analysts' estimates in the third quarter and raised its guidance for this year again. 
Via The Motley Fool
Wall Street Crime And Punishment: The Blood On Elizabeth Holmes' Fingers
Does crime pay? Wall Street Crime and Punishment is a weekly series by Benzinga's Phil Hall chronicling the bankers, brokers and financial ne’er-do-wells whose ambition... 
Via Benzinga
What 5 Analyst Ratings Have To Say About Quest Diagnostics
Within the last quarter, Quest Diagnostics (NYSE:DGX) has observed the follow... 
Via Benzinga
Quest Diagnostics Inc (DGX) Q3 2021 Earnings Call Transcript
DGX earnings call for the period ending September 30, 2021. 
Via The Motley Fool
Topics Earnings
Exposures Financial
Quest Diagnostics: Q3 Earnings Insights
Quest Diagnostics (NYSE:DGX) reported its Q3 earnings results on Thursday, October 21, 2021 at 06:45 AM. Here's what investors need to know about the announcement.... 
Via Benzinga
Quest Raises FY21 Outlook Again On Strong COVID-19 Volumes In Q3
Quest Diagnostics Incorporated (NYSE: DGX) has posted a better-than-expected Q3 adjusted EPS of $3.96, down 7.9% Y/Y, beating the consensus estimate of $2.87. Sales... 
Via Benzinga
Exposures COVID-19
The Daily Biotech Pulse: FDA Authorizes Moderna, J&J Booster Shots; Regulatory Approvals For Bristol-Myers Squibb, Sanofi-Regeneron; Ventyx IPO
Here's a roundup of top developments in the biotech space over the last 24 hours: Stocks In Focus CDC Committee Recommends Approval Of Merck, Pfizer's Pneumococcal Vaccine... 
Via Benzinga
Exposures Product Safety
Earnings Scheduled For October 21, 2021
Companies Reporting Before The Bell • Tri Pointe Homes (NYSE:TPH) is estimated to report quarterly earnings at $0.89 per share on revenue of $946.97 million. •... 
Via Benzinga
Earnings Outlook For Quest Diagnostics
Quest Diagnostics (NYSE:DGX) is set to give its latest quarterly earnings report on Thursday, 2021-10-21. Here's what investors need to know before the announcement. Analysts... 
Via Benzinga
< Previous 1 2 3 4 5 6 7 8 9 10 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms Of Service.